 |
 |
 |
 |
 |
 |
|
Press Releases
Alios BioPharma Issued Broad U.S. Patent for Glyco-engineered Interferons
Alios BioPharma, Inc. has appointed Plexxikon Founder and Chief Executive Officer K. Peter Hirth, Ph
Alios BioPharma, Inc. Closes $32 Million Series A Financing
Alios BioPharma, Inc. Completes First Closing of Series A Financing with Commitment of $24 MM from 3
DEVELOPMENT OF NOVEL HYPERGLYGOSYLATED TYPE 1 INTERFERONS: A STRATEGY TO IMPROVE PK PERFORMANCE WITHOUT LOSS OF BIOLOGICAL POTENCY
Alios BioPharma Licenses RNase L Activators from Cleveland Clinic for Antiviral and Anticancer Therapeutics
-- Company Plans to Develop New Class of Broad Spectrum Drugs for the Treatment of Viral Diseases and Cancer --
|
